Paper
海绵种类未注明
Design, fabrication, and evaluation of antimicrobial sponge microneedles for the transdermal delivery of insulin
- Drug Delivery
- 2025
摘要 (Abstract)
原文照录自出处。可通过上方链接阅读全文。
Transdermal drug delivery systems hold promise, but their effectiveness is often constrained by the skin's barrier. Microneedles (MNs) improve drug permeability by creating micro-channels in the skin, yet they continue to face challenges such as infection risks and safety concerns. To overcome these challenges, a novel antimicrobial sponge MNs (ASMNs@PVP-INS) modified with polyvinylpyrrolidone (PVP) for insulin (INS) delivery was designed. Mechanical testing demonstrated that these MNs possess excellent mechanical strength, capable of withstanding at least 0.11 N per needle without rupture. In vitro drug penetration tests revealed that the MNs consistently released over 75 % of INS within a 6 h. In an animal model, ASMNs@PVP-INS reduced initial blood glucose levels from 22.4 to 5.72 mmol/L, effectively maintaining glucose control for more than 6 h without inducing hypoglycemia. Additionally, agar diffusion assays indicated that INS loading did not compromise the antimicrobial properties of antimicrobial sponge MNs (ASMNs). Skin irritation tests showed that ASMNs@PVP-INS exhibited mild irritation (PII < 0.6), with skin damage fully recovering within 8 h. Safety assessments indicated no significant toxicity to mice, with biochemical markers remaining within normal ranges, thereby confirming their good biocompatibility. In conclusion, ASMNs@PVP-INS hold promise as a novel drug delivery vehicle.
Keywords
Citation
Zhang X, Zhang Y, Zheng H, Yang X, Zou S, Chen J (2025). Design, fabrication, and evaluation of antimicrobial sponge microneedles for the transdermal delivery of insulin. Eur J Pharm Biopharm. https://doi.org/10.1016/j.ejpb.2024.114586